Monica Sandri
(CNR-ISSMC Institute of Science, Technology and Sustainability for Ceramics, Italy)

Monica Sandri is Director of Research at the National Research Council of Italy (CNR), Institute of Science, Technology and Sustainability for Ceramics (ISSMC, ex ISTEC), with expertise on the design and development of hybrid biomaterials and bioceramic for tissue regeneration, nanomedicine, personalized therapies, and cosmetic. Coordinator of the research activity aimed at the study of biomineralization processes for the attainment of biomimetic nanostructured hybrid and polymer hydrogels and bioinks finalized at the development of 3D scaffolds for tissues regeneration (bone, cartilage, skin tissues) with geometry, porosity and structural and mechanical performances modulated by means of 3D printing and mold-freeze-casting techniques. Development of biomimetic and medicated membranes for chronic wound management capable of simultaneously fighting infections and guiding tissue healing and regeneration. Design and development of biomatrices for 3D in vitro predictive models, through 3D bioprinting and co-cultures approaches, aimed at the study of personalized targeted pharmacological therapies in the field of tumor and infectious diseases (e.g. investigation on osteosarcoma, leukemia, osteomyelitis). Scientific responsible of many funded European Projects, Coordinator of National and Regional Research Projects. Graduated in Chemistry in 2001 from the Alma Mater Studiorum, University of Bologna, Italy and obtained the PhD degree in Material Science in 2006. She has authored more than 140 papers published in international peer-reviewed journals, 13 book chapters and 4 Patents. H-index = 40, total citations > 5688 (Source: Scopus).

Nurulhuda Mohd
(Department of Restorative Dentistry, Faculty of Dentistry, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia)

Dr Nurulhuda Mohd is a lecturer and consultant Periodontist in the Department of Restorative Dentistry, Faculty of Dentistry, Universiti Kebangsaan Malaysia. Her specialisation is in the diagnosis and treatment of gum diseases and oral inflammation. She received her degree of Doctor of Dental Surgery (DDS) from Universiti Sains Malaysia (USM) and then completed her specialty training in King’s College London obtaining Master of Clinical Dentistry (MClintDent) in Periodontology. She holds the award of Membership in Periodontics from Royal College of Surgeons of Edinburgh, and has been appointed for various positions in Malaysian Society of Periodontology since 2016.

Dr. Nurulhuda Mohd is currently pursuing a PhD programme in tissue engineering at Universiti Kebangsaan Malaysia. Her research in tissue engineering is focused on 3D printing technologies for dental applications, specifically developing a suitable biomaterial using hydroxyapatite to enable customised fabrication of 3D printed scaffolds.

Her other research interest includes the use of natural products in dentistry such as miswak (Salvadora persica) and olive oil, and also investigating the relationship between periodontal and systemic diseases. She welcomes collaboration for interdisciplinary research especially from material and chemical engineering background.

monica sandri
(CNR-ISSMC, Italy)

Monica Sandri is Director of Research at the National Research Council of Italy (CNR), Institute of Science, Technology and Sustainability for Ceramics (ISSMC, ex ISTEC), with expertise on the design and development of hybrid biomaterials and bioceramic for tissue regeneration, nanomedicine, personalized therapies, and cosmetic. Coordinator of the research activity aimed at the study of biomineralization processes for the attainment of biomimetic nanostructured hybrid and polymer hydrogels and bioinks finalized at the development of 3D scaffolds for tissues regeneration (bone, cartilage, skin tissues) with geometry, porosity and structural and mechanical performances modulated by means of 3D printing and mold-freeze-casting techniques. Development of biomimetic and medicated membranes for chronic wound management capable of simultaneously fighting infections and guiding tissue healing and regeneration. Design and development of biomatrices for 3D in vitro predictive models, through 3D bioprinting and co-cultures approaches, aimed at the study of personalized targeted pharmacological therapies in the field of tumor and infectious diseases (e.g. investigation on osteosarcoma, leukemia, osteomyelitis). Scientific responsible of many funded European Projects, Coordinator of National and Regional Research Projects. Graduated in Chemistry in 2001 from the Alma Mater Studiorum, University of Bologna, Italy and obtained the PhD degree in Material Science in 2006. She has authored more than 140 papers published in international peer-reviewed journals, 13 book chapters and 4 Patents. H-index = 40, total citations > 5688 (Source: Scopus).

Pascale Chevallier
(Laval University, Canada)

In Pr. Mantovani’s laboratory since 2000. Responsible of research activities on polymeric coatings, nanocoatings, functionalization for medical devices, Pascale is an expert in interfaces and surface characterization for biological applications. She is involved in several industrial and academic driven projects at Canadian and international level.

Nurulhuda Mohd
(Universiti Kebangsaan Malaysia, Malaysia)

Dr Nurulhuda Mohd is a lecturer and consultant Periodontist in the Department of Restorative Dentistry, Faculty of Dentistry, Universiti Kebangsaan Malaysia. Her specialisation is in the diagnosis and treatment of gum diseases and oral inflammation. She received her degree of Doctor of Dental Surgery (DDS) from Universiti Sains Malaysia (USM) and then completed her specialty training in King’s College London obtaining Master of Clinical Dentistry (MClintDent) in Periodontology. She holds the award of Membership in Periodontics from Royal College of Surgeons of Edinburgh, and has been appointed for various positions in Malaysian Society of Periodontology since 2016.

Dr. Nurulhuda Mohd is currently pursuing a PhD programme in tissue engineering at Universiti Kebangsaan Malaysia. Her research in tissue engineering is focused on 3D printing technologies for dental applications, specifically developing a suitable biomaterial using hydroxyapatite to enable customised fabrication of 3D printed scaffolds.

Her other research interest includes the use of natural products in dentistry such as miswak (Salvadora persica) and olive oil, and also investigating the relationship between periodontal and systemic diseases. She welcomes collaboration for interdisciplinary research especially from material and chemical engineering background.

Justy N Francis
(Indian Institute of Technology, Jodhpur, India)

A dentist turned researcher with interests inclined toward implantable biomaterials and patient-specific implants (PSI). Currently working on 3D printable PEEK composite-based patient-specific implants (PSI). Before research, I worked as a clinician and a medical officer during COVID-19 with the National Health Mission, Government of India. The huge number of mucormycosis cases that arose during COVID-19 was my biggest motivation for my current project on PEEK-based patient-specific implants. At present, I am enrolled for the dual degree (Masters-PhD) at the Medical Technology joint program jointly conducted by IIT Jodhpur and AIIMS Jodhpur.

Donny Hanjaya-Putra
(University of Notre Dame, USA)

Donny Hanjaya-Putra is an Assistant Professor in the Department of Aerospace and Mechanical Engineering, Bioengineering Graduate Program, as well as Chemical and Biomolecular Engineering at the University of Notre Dame. He earned his Bachelor degree in Chemical and Biomolecular Engineering from the University of Notre Dame in 2007. He completed his PhD in Chemical and Biomolecular Engineering from the Johns Hopkins University in 2012 under the mentorship of Dr. Sharon Gerecht. His postdoctoral research training was conducted with Dr. Elliot L. Chaikof at the Wyss Institute for Biologically Inspired Engineering at Harvard Medical School.

His research focuses on the study of thrombosis and hemostasis, stem cell engineering, vascular and lymphatic morphogenesis, as well as synthesis of bio-inspired materials and tissue-engineered constructs. His lab is interested to understand what governs the formation of blood and lymphatic vessels from stem cells and how these insights can be used to develop novel therapies. He has received numerous awards, including NIH Maximizing Investigator’s Research Award (MIRA) R35, NSF CAREER Award, Career Development Award from American Heart Association, CMBE Young Innovator Award, and Siebel Scholar Award. Research projects in his lab are currently being supported by both federal and private funding agencies, including Indiana CTSI, NSF, NIH, DoD Advanced Regenerative Manufacturing Institute / BioFab USA, and American Heart Association.

Rajendra Kumar Singh
(Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Republic of Korea, Korea, Republic of)

Rajendra K. Singh received his BSc degree from Banaras Hindu University (BHU) in India in 2002, an MS degree from the Indian Institute of Technology Roorkee (IITR) in 2004, and a Ph.D. degree from the Indian Institute of Technology Guwahati (IITG) in 2009. He worked as a postdoctoral researcher from 2010 to 2013 and as a research professor from 2014 to 2022 at Dankook University, South Korea. Presently, he is an assistant professor at ITREN, Dankook University, South Korea, since 2023. He has published more than 80 papers in reputed journals and holds 12 patents, with a research Google citation of 7066, h-index of 41 and i10-index of 104. His current research interests are Nanomaterials, Scaffolds, Therapeutics, cell-biomaterial interactions for tissue regeneration, and cancer theranostics.

Donny Hanjaya-Putra
(University of Notre Dame, USA)

Donny Hanjaya-Putra is an Assistant Professor in the Department of Aerospace and Mechanical Engineering, Bioengineering Graduate Program, as well as Chemical and Biomolecular Engineering at the University of Notre Dame. He earned his Bachelor degree in Chemical and Biomolecular Engineering from the University of Notre Dame in 2007. He completed his PhD in Chemical and Biomolecular Engineering from the Johns Hopkins University in 2012 under the mentorship of Dr. Sharon Gerecht. His postdoctoral research training was conducted with Dr. Elliot L. Chaikof at the Wyss Institute for Biologically Inspired Engineering at Harvard Medical School.

His research focuses on the study of thrombosis and hemostasis, stem cell engineering, vascular and lymphatic morphogenesis, as well as synthesis of bio-inspired materials and tissue-engineered constructs. His lab is interested to understand what governs the formation of blood and lymphatic vessels from stem cells and how these insights can be used to develop novel therapies. He has received numerous awards, including NIH Maximizing Investigator’s Research Award (MIRA) R35, NSF CAREER Award, Career Development Award from American Heart Association, CMBE Young Innovator Award, and Siebel Scholar Award. Research projects in his lab are currently being supported by both federal and private funding agencies, including Indiana CTSI, NSF, NIH, DoD Advanced Regenerative Manufacturing Institute / BioFab USA, and American Heart Association.

Rajendra Kumar Singh
(ITREN, Dankook University, South Korea, Korea, Republic of)

Rajendra K. Singh received his BSc degree from Banaras Hindu University (BHU) in India in 2002, an MS degree from the Indian Institute of Technology Roorkee (IITR) in 2004, and a Ph.D. degree from the Indian Institute of Technology Guwahati (IITG) in 2009. He worked as a postdoctoral researcher from 2010 to 2013 and as a research professor from 2014 to 2022 at Dankook University, South Korea. Presently, he is an assistant professor at ITREN, Dankook University, South Korea, since 2023. He has published more than 80 papers in reputed journals and holds 12 patents, with a research Google citation of 7066, h-index of 41 and i10-index of 104. His current research interests are Nanomaterials, Scaffolds, Therapeutics, cell-biomaterial interactions for tissue regeneration, and cancer theranostics.

Ipsita Roy
(University of Sheffield, United Kingdom)

Professor Ipsita Roy, Professor of Biomaterials, Department of Materials Science and Engineering, University of Sheffield, is an expert in microbial biotechnology, natural biobased materials, and their biomedical and environmental applications. Professor Roy was awarded the prestigious Inlaks Scholarship to study for her Ph.D. at the University of Cambridge, UK. At Cambridge, she was awarded scholarships including the Churchill College Scholarship and the Cambridge University Philosophical Society Fellowship Award. Her postdoctoral work was at the University of Minnesota, USA. She has published over 100 papers in high ‘Impact Factor’ journals such as Biomaterials, ACS Applied Materials Interfaces, with an H index of 47. She is a fellow of the Royal Society of Biology and the Institute of Materials, Minerals and Mining (IOM3). Her group is focussed on the production of novel natural and sustainable polymers such as Polyhydroxyalkanoates, Bacterial cellulose, Alginate and their biomedical and environmental applications. She is an editor of Scientific Reports and Biomedical Materials. Her total grant portfolio is more than 14 million pounds. She has many patents, and she is in the process of spinning out a company called PHAsT, focused on the production of biobased materials for biomedical applications.

Ipsita Roy
(University of Sheffield, United Kingdom)

Professor Ipsita Roy, Professor of Biomaterials, Department of Materials Science and Engineering, University of Sheffield, is an expert in microbial biotechnology, natural biobased materials, and their biomedical and environmental applications. Professor Roy was awarded the prestigious Inlaks Scholarship to study for her Ph.D. at the University of Cambridge, UK. At Cambridge, she was awarded scholarships including the Churchill College Scholarship and the Cambridge University Philosophical Society Fellowship Award. Her postdoctoral work was at the University of Minnesota, USA. She has published over 100 papers in high ‘Impact Factor’ journals such as Biomaterials, ACS Applied Materials Interfaces, with an H index of 47. She is a fellow of the Royal Society of Biology and the Institute of Materials, Minerals and Mining (IOM3). Her group is focussed on the production of novel natural and sustainable polymers such as Polyhydroxyalkanoates, Bacterial cellulose, Alginate and their biomedical and environmental applications. She is an editor of Scientific Reports and Biomedical Materials. Her total grant portfolio is more than 14 million pounds. She has many patents, and she is in the process of spinning out a company called PHAsT, focused on the production of biobased materials for biomedical applications.

Hanif Haidari
(Future Industries Institute, University of South Australia, Mawson Lakes SA 5095, Australia)

Dr. Haidari obtained his Ph.D. from the University of South Australia in 2021. He has established an outstanding cross-disciplinary research profile in understanding and synthesizing metallic nanoparticles aiming to address the prevailing challenges posed by drug-resistant bacterial infections. His innovative and translational approach has led to major contributions underpinning the development of a smart hydrogel delivery system for localized and targeted approaches to eliminate chronic infections. Dr. Haidari's commitment to research excellence is underscored by his rapidly expanding portfolio of research publications in esteemed academic journals. His collaborative efforts extend across national and international levels, fostering vital partnerships that drive the development of novel therapeutics for chronic wounds. His leadership and contribution have been recognized through numerous prestigious awards including AWTRS Young Investigator of the Year 2021, FII Directors Junior Research Award 2022 as well as competitive travel and research grants. Dr. Haidari is an eager early-career researcher, driven by a strong commitment to his ongoing growth and development. His aspiration is to achieve international recognition as a research leader dedicated to advancing cutting-edge, next-generation technologies for the treatment of chronic infected wounds.

Hanif Haidari
(University of South Australia, Australia)

Dr. Haidari obtained his Ph.D. from the University of South Australia in 2021. He has established an outstanding cross-disciplinary research profile in understanding and synthesizing metallic nanoparticles aiming to address the prevailing challenges posed by drug-resistant bacterial infections. His innovative and translational approach has led to major contributions underpinning the development of a smart hydrogel delivery system for localized and targeted approaches to eliminate chronic infections. Dr. Haidari's commitment to research excellence is underscored by his rapidly expanding portfolio of research publications in esteemed academic journals. His collaborative efforts extend across national and international levels, fostering vital partnerships that drive the development of novel therapeutics for chronic wounds. His leadership and contribution have been recognized through numerous prestigious awards including AWTRS Young Investigator of the Year 2021, FII Directors Junior Research Award 2022 as well as competitive travel and research grants. Dr. Haidari is an eager early-career researcher, driven by a strong commitment to his ongoing growth and development. His aspiration is to achieve international recognition as a research leader dedicated to advancing cutting-edge, next-generation technologies for the treatment of chronic infected wounds.

Rui Reis
(3B's Research Group/Univ. Minho, Portugal)

Rui L. Reis, PhD, DSc, Hon. Causa MD, Hon Causa PhD, FBSE, FTERM, member of NAE, FAIMBE, FEAMBES, is a Full Professor of Tissue Engineering, Regenerative Medicine, Biomaterials and Stem Cells at University of Minho (UMinho), Portugal. He is the Founding Director of the 3B’s Research Group and Dean/President of the I3Bs – Institute for Biomaterials, Biodegradables and Biomimetics at UMinho. He is also the CEO of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine and has been the Global President of the Tissue Engineering and Regenerative Medicine International Soc. (TERMIS). He is Associate Editor of PNAS-NEXUS and is in the Editorial Board of several other relevant journals. He co-founded several companies that raised important private investments. His work has been cited more than 98000 times and he is listed in the annual Highly Cited Researchers 2022 and 2023 list from Clarivate. He has been awarded many important international prizes.

Milica Radisic
(University of Toronto, Canada)

Dr. Milica Radisic is a Professor at the University of Toronto, Tier 1 Canada Research Chair in Organ-on-a-Chip Engineering and a Senior Scientist at the Toronto General Research Institute. She is also Director of the NSERC CREATE Training Program in Organ-on-a-Chip Engineering & Entrepreneurship and a co-lead for the Center for Research and Applications in Fluidic Technologies. She is a Fellow of the Royal Society of Canada-Academy of Science, Canadian Academy of Engineering, the American Institute for Medical & Biological Engineering, Tissue Engineering & Regenerative Medicine Society as well as Biomedical Engineering Society. She was a recipient of the MIT Technology Review Top 35 Under 35, Queen Elizabeth II Diamond Jubilee Medal, NSERC E.W.R Steacie Fellowship, YWCA Woman of Distinction Award, Killam Fellowship, Acta Biomaterialia Silver Medal, and Humboldt Research Award to name a few. Her research focuses on organ-on-a-chip engineering and development of new biomaterials that promote healing and attenuate scarring. She developed new methods to mature iPSC derived cardiac tissues using electrical stimulation. She is an Executive Editor for ACS Biomaterials Science & Engineering, Senior Consulting Editor for the Journal of Molecular and Cellular Cardiology, a reviewing editor for eLife and a member of the editorial board of another 8 journals. She served on the Board of Directors for Ontario Society of Professional Engineers, Canadian Biomaterials Society and McMaster University Alumni Association. She organized Keystone, EMBO and ECI conferences and numerous sessions at TERMIS and BMES meetings. She served as a Scientific Officer for the Canadian Institutes of Health Research and member of review panels for CIHR, NIH and Israel Ministry of Education. She is the Chair of Investment Committee for Serbia Innovation Fund. She is a co-founder of two companies TARA Biosystems (acquired by Valo Health), that uses human engineered heart tissues in drug development and safety testing, and Quthero that advances regenerative hydrogels. Her work has been presented in over 260 publications, garnering over 20,000 citations with an h-index of 71. Her publications appeared in Cell, Nature Materials, Nature Methods, Nature Protocols, Nature Communications, PNAS etc.

Changyou Gao
(Zhejiang University, China)

Changyou Gao graduated from Department of Chemistry, Jilin University to get his Bachelor degree (1990), Master degree (1993) and Ph.D of Polymer Chemistry and Physics (1996). From 1996 to 1998, he worked in Department of Polymer Science and Engineering of Zhejiang University as a postdoctor fellowship. He was a DAAD and visiting scholar in Germany (1999). He is a Cheung Kong Scholar of Ministry of Education of China, a winner for the National Science Fund for Distinguished Young Scholars of China, a fellow of the international federation of biomaterial science and engineering societies, the American Institute of Medicinal and Biological Engineering, Royal Society of Chemistry, and Chinese Society of Biomaterials. He is now serving as an associate president of Chinese Society of Biomaterials, and an associate editor of Biomaterials Advances and Progress in Materials Science. His research interests include self-adaptive biomaterials, immuno-modulation biomaterials, anti-bacterial biomaterials and their applications in tissue repair and regeneration. He has published more than 500 papers with an H-index of 78.

Laura Poole-Warren
(The University of New South Wales, Australia)

Laura is a Professor in Biomedical Engineering at UNSW and leads a research group focussed on design and development of novel materials for neural electrodes and other soft-tissue interfaces, and on 3D engineered neural tissue models. A key theme of her work is on understanding material and device compatibility with cells and tissues. Throughout her career, she has worked across academia, industry, and government. She was a research professor at the New Jersey Centre for Biomaterials based at Rutgers University in the USA and a preclinical scientist in the biomedical industry working on development of wound dressings and embolic agents for cancer treatment from 1999 to 2001. She also served from 2003 to 2013 as a member of the Australian Government Therapeutic Goods Administration statutory expert committee on the safety of medical devices. Between 2005 and 2018, Laura held various leadership appointments at UNSW as Pro Vice-Chancellor, and Dean of Graduate Research, as well as being the Australian representative on the International Union of Societies of Biomaterials Science and Engineering. She was awarded honours in January 2020 as a Member of the Order of Australia (AM) for service to Biomedical Engineering and education, is a Fellow of three academies, FTSE, FAIMBE and FBSE and the Royal Society of NSW

Bikramjit Basu
(Indian Institute of Science, Bangalore, India)

Dr. Bikramjit Basu is a Professor at the Indian Institute of Science, Bangalore, India, since 2011 and earlier served on the faculty of the Indian Institute of Technology Kanpur (2001-2011). He has been pursuing research at the confluence of Materials Science, Additive Manufacturing, Biological Science, and Medicine, to address many unanswered questions related to regenerative engineering and reconstructive surgeries. His research group has effectively applied the principles and tools of these disciplines to develop next-generation implants and bioengineering solutions to address unmet clinical needs for musculoskeletal, dental, and neurosurgical applications; thereby impacting human healthcare. His research group has developed technologies related to the manufacturing of bioceramics, acetabular liners, customized bone flaps for cranioplasty surgeries, dental implants and variants of hydrogels. These technologies are transferred to multinational corporates or start-ups, and many of the products, after regulatory clearances, are currently used for patient care in India.
A Chartered Engineer of the UK, he has the unique distinction of being the only ceramic scientist from India to get elected to all the major international societies and academies, including the World Academy of Ceramics (2024), the European Ceramic Society (2023), the American Ceramic Society (2019). In India, he is the only engineering scientist to get elected as a Fellow of all the National Academies of Engineering, Science and Medicine, including the Indian National Science Academy (2021), Indian Academy of Sciences (2020), American Ceramic Society (2019), National Academy of Medical Sciences (2017), Indian National Academy of Engineering (2015), and National Academy of Sciences, India (2013). Internationally, he is an elected fellow of the International Union of Societies for Biomaterials Science and Engineering (2020), International Academy of Medical and Biological Engineering (2017) and the American Institute of Medical and Biological Engineering (2015). He is a recipient of India’s most prestigious Science and Technology award, Shanti Swarup Bhatnagar Prize (2013) from the Prime Minister of India; and globally competent awards, like Humboldt Research Award from the Alexander von Humboldt foundation (2022), and International Richard Brook Award from the European Ceramic Society (2022). He is currently serving on many advisory panels of the national institutes, European university and federal funding agencies as well as major multinational corporates. As the current President of the Society for Biomaterials and Artificial Organs India (1000+ members across India, US and Europe) and in his leadership roles as the Chair of Bioceramics Division and other principal committees of the American Ceramic Society (ACerS), he has brought transformative changes to significantly enhance international visibility of the biomaterials programs in different countries, while inspiring several hundreds of young researchers in Bioceramics area across the world. Such activities together with his roles as the lead investigator in several multi-institutional network programs including multicentric clinical studies enabled creating a vibrant translational ecosystem, to bring together key stakeholders (industry professionals and clinicians) on the innovation platform in India.

Jurica Bauer
(Maastricht University, Netherlands)

Dr. Jurica Bauer graduated in chemistry from the University of Zagreb, Croatia, where he developed a passion for research and teaching. Having worked as medicinal chemist at GlaxoSmithKline for a few years, he moved to The Netherlands to pursue a PhD degree in the field of molecular motors and machines with Professor Feringa at the University of Groningen. As a postdoctoral researcher in the group of Professor Broer at the Eindhoven University of Technology and in collaboration with Philips, he developed a smart liquid-crystalline polymer coating for LEDs to fine-tune the properties of emitted light. In 2014 he was appointed Lecturer in Chemistry at the Inholland University of Applied Sciences in Amsterdam where he developed a new Polymer Chemistry minor and acted as graduation and internationalization coordinator. In 2020 he joined the MERLN Institute at the Maastricht University as Assistant Professor of Education to coordinate the design and development of a new undergraduate study program in the field of Regenerative Medicine and Technology. He is also involved in ongoing teaching and research activities within the institute. His interests include innovation and research in STEM education and scientific research in the field of smart, and especially photoresponsive, nanobiomaterials for medicinal applications.

Young Jung No
(The University of Sydney, Australia)

Dr Young No is a biomaterials engineer, Lecturer (US: Assistant Professor) and Deputy Head of School (Education) at the School of Biomedical Engineering at the University of Sydney, and also served as acting Associate Dean (Learning and Teaching) at the Faculty of Engineering in early 2023. Dr No was also awarded “40 under 40 Most Influential Asian-Australian for 2022” by the Asian-Australian Leadership Summit for his leadership in biomedical engineering programs at the University of Sydney, shaping the curriculum to be the most comprehensive in the southern hemisphere in terms of topics and areas covered to match the rapidly rising importance and relevance of biomedical engineering in the modern-day technological setting. His innovative and engaging teaching practices in his classes have been well-recognised, with multiple commendations received for his courses, teaching awards, and being featured in university videos for World Teachers’ Day in 2023. Dr No has also led and contributed significantly to biomedical engineering outreach, resulting in significantly increased interest in biomedical engineering amongst prospective students and subsequently increased number of students pursuing biomedical engineering at the University of Sydney for their professional careers.

Dr No’s area of research is in the engineering and characterising novel synthetic bioactive materials for musculoskeletal applications, with primary focus on developing novel cements and ceramic composites. He has published 17 peer-reviewed journal articles, with all publications in journals ranked in the top 30% (Scimago Journal Rank) in the fields of materials science and biomedical engineering, including in high impact journals in the field, and has two published patents as primary co-inventor. His research on the synthetic biomaterials has been the subject of multiple successful grant applications, including the Australian Research Council Linkage Grant as well as other grants including the University of Sydney Commercial Development and Industry Partnership Fund, Australia–Germany Joint Research Co-operation Scheme (DAAD), and Harvard Mobility Scheme. YJN’s work has also been recognised for impact and won presentation awards in conferences including the Australia New Zealand Orthopaedic Research Society (ANZORS), and TERMIS-AP.

Johnna S. Temenoff
(Georgia Tech and Emory University, USA)

Dr. Johnna S. Temenoff is the Carol Ann and David D. Flanagan Professor the Coulter Department of Biomedical Engineering at Georgia Tech/Emory University. She is also currently the Director of the NSF Engineering Research Center in Cell Manufacturing Technologies (CMaT) and the Director of the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M). Scientifically, Dr. Temenoff is interested in scaling culture of therapeutic cells and tailoring the molecular interactions between glycosaminoglycans and proteins/cells for use in regenerative medicine applications. Her laboratory focuses primarily on promoting repair after injuries to the tissues of the shoulder, including cartilage, tendon, and muscle.

Jurica Bauer
(Maastricht University, Netherlands)

Dr. Jurica Bauer graduated in chemistry from the University of Zagreb, Croatia, where he developed a passion for research and teaching. Having worked as medicinal chemist at GlaxoSmithKline for a few years, he moved to The Netherlands to pursue a PhD degree in the field of molecular motors and machines with Professor Feringa at the University of Groningen. As a postdoctoral researcher in the group of Professor Broer at the Eindhoven University of Technology and in collaboration with Philips, he developed a smart liquid-crystalline polymer coating for LEDs to fine-tune the properties of emitted light. In 2014 he was appointed Lecturer in Chemistry at the Inholland University of Applied Sciences in Amsterdam where he developed a new Polymer Chemistry minor and acted as graduation and internationalization coordinator. In 2020 he joined the MERLN Institute at the Maastricht University as Assistant Professor of Education to coordinate the design and development of a new undergraduate study program in the field of Regenerative Medicine and Technology. He is also involved in ongoing teaching and research activities within the institute. His interests include innovation and research in STEM education and scientific research in the field of smart, and especially photoresponsive, nanobiomaterials for medicinal applications.

Young Jung No
(The University of Sydney, Australia)

Dr Young No is a biomaterials engineer, Lecturer (US: Assistant Professor) and Deputy Head of School (Education) at the School of Biomedical Engineering at the University of Sydney, and also served as acting Associate Dean (Learning and Teaching) at the Faculty of Engineering in early 2023. Dr No was also awarded “40 under 40 Most Influential Asian-Australian for 2022” by the Asian-Australian Leadership Summit for his leadership in biomedical engineering programs at the University of Sydney, shaping the curriculum to be the most comprehensive in the southern hemisphere in terms of topics and areas covered to match the rapidly rising importance and relevance of biomedical engineering in the modern-day technological setting. His innovative and engaging teaching practices in his classes have been well-recognised, with multiple commendations received for his courses, teaching awards, and being featured in university videos for World Teachers’ Day in 2023. Dr No has also led and contributed significantly to biomedical engineering outreach, resulting in significantly increased interest in biomedical engineering amongst prospective students and subsequently increased number of students pursuing biomedical engineering at the University of Sydney for their professional careers.

Dr No’s area of research is in the engineering and characterising novel synthetic bioactive materials for musculoskeletal applications, with primary focus on developing novel cements and ceramic composites. He has published 17 peer-reviewed journal articles, with all publications in journals ranked in the top 30% (Scimago Journal Rank) in the fields of materials science and biomedical engineering, including in high impact journals in the field, and has two published patents as primary co-inventor. His research on the synthetic biomaterials has been the subject of multiple successful grant applications, including the Australian Research Council Linkage Grant as well as other grants including the University of Sydney Commercial Development and Industry Partnership Fund, Australia–Germany Joint Research Co-operation Scheme (DAAD), and Harvard Mobility Scheme. YJN’s work has also been recognised for impact and won presentation awards in conferences including the Australia New Zealand Orthopaedic Research Society (ANZORS), and TERMIS-AP.

Jeong-Kee Yoon
(Chung-Ang University, Korea, Republic of)

Dr. Jeong-Kee Yoon is an associate professor in the Department of Systems Biotechnology at Chung-Ang University, Republic of Korea. He received his Ph.D. degree from Seoul National University, Republic of Korea in 2017, and worked as a postdoctoral researcher at Georgia Institute of Technology until 2021. His research interests are at the interface of regenerative medicine and biomedical engineering, primarily focused on vascular engineering using stem cells, engineered exosomes, and 3D cell culture methods for tissue regeneration and disease modeling. He has published 51 peer-reviewed articles, and is a co-inventor on two registered patents. In terms of education, he teaches Organic Chemistry, Biomaterials, and Biomedical Engineering to undergraduates of non-engineering majors, and Tissue Engineering and Regenerative Medicine to graduate students. He has been selected twice (in 2022 and 2023) as a Teacher of Excellence at Chung-Ang University based on surveys completed by 70-80 students per class.

Hyuk Sang Yoo
(Kangwon National University, Korea, Republic of)

He received a B.S. degree (1996), a M.S. degree (1998), and a Ph.D. degree (2002, Advisor: Professor Tae Gwan Park) at Department of Biological Sciences, Korea Advanced Institute of Science and Technology. After a post-doctoral fellow at Department of Biomedical Engineering, the Johns Hopkins University (2004, Advisor: Professor Kam W. Leong), he joined the Kangwon National University as an assistant professor (2005). He is now a tenured professor of Biomedical Materials Engineering. He was also a visiting scholar for the Johns Hopkins University (2005) and the Northwestern University (2010). His research is focused on nano-biomaterials for drug delivery and tissue engineering employing multifunctional nanofibers and nanoparticles.

Katja Schenke-Layland
(Eberhard Karls University Tubingen, Germany)

Katja Schenke-Layland is the Professor of Medical Technologies and Regenerative Medicine at the Medical Faculty of the University Tübingen (MFT). She is the Director of the NMI Natural and Medical Sciences Institute in Reutlingen, the CEO of the NMI-TT GmbH, and the Study Dean of Medical Technologies at the University of Tübingen. Katja is currently the Co-Editor-In-Chief of Tissue Engineering Part B (Mary Ann Liebert) and Executive Editor of Advanced Drug Delivery Reviews (Elsevier), as well as on several editorial boards such as Matrix Biology (Elsevier), Current Opinion in Biomedical Engineering (Elsevier), and Journal of 3D Printing in Medicine (Future Medicine). Katja is a fellow/ board member of the German National Academy of Science and Engineering (acatech), the German Central Ethics Committee for Stem Cell Research (ZES), International and German Societies of Matrix Biology, and the European Alliance for Medical and Biological Engineering and Science (EAMBES). She has published more than 190 peer-reviewed articles, has an h-index of 51 (Scopus), and has been granted 4 patents.

Kent Leach
(University of California Davis, USA)

J. Kent Leach is the Lawrence J. Ellison Endowed Professor of Musculoskeletal Research and Vice Chair of Research in the Department of Orthopaedic Surgery and Professor of Biomedical Engineering at the University of California, Davis. His research interests are focused on developing cell-instructive biomaterials for tissue engineering of replacement tissues and cultivated meat, applying transport principles for growth of engineered tissues and modeling cancer, and translation from the bench to the clinic. He is the Editor-in-Chief of the Journal of Biomedical Materials Research Part A, the official journal of the Society for Biomaterials (SFB). He was inducted into the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE) in 2017 and as a Fellow of the Biomedical Engineering Society in 2018. He is the Program Director of one of eight NIH-funded predoctoral training grants focused on musculoskeletal health nationally. He has received multiple teaching and mentorship awards at UC Davis, and he holds various leadership roles in his scientific communities including the Board of Directors of BMES and within the Orthopaedic Research Society (ORS).

Katja Schenke-Layland
(Eberhard Karls University Tubingen, Germany)

Katja Schenke-Layland is the Professor of Medical Technologies and Regenerative Medicine at the Medical Faculty of the University Tübingen (MFT). She is the Director of the NMI Natural and Medical Sciences Institute in Reutlingen, the CEO of the NMI-TT GmbH, and the Study Dean of Medical Technologies at the University of Tübingen. Katja is currently the Co-Editor-In-Chief of Tissue Engineering Part B (Mary Ann Liebert) and Executive Editor of Advanced Drug Delivery Reviews (Elsevier), as well as on several editorial boards such as Matrix Biology (Elsevier), Current Opinion in Biomedical Engineering (Elsevier), and Journal of 3D Printing in Medicine (Future Medicine). Katja is a fellow/ board member of the German National Academy of Science and Engineering (acatech), the German Central Ethics Committee for Stem Cell Research (ZES), International and German Societies of Matrix Biology, and the European Alliance for Medical and Biological Engineering and Science (EAMBES). She has published more than 190 peer-reviewed articles, has an h-index of 51 (Scopus), and has been granted 4 patents.

Fan Yang
(Stanford University School of Medicine, USA)

Fan Yang is an Associate Professor with tenure at Stanford University with joint appointments in the Departments of Bioengineering and Orthopaedic Surgery, and Director of Stanford Stem Cells and Biomaterials Engineering Laboratory. Her research seeks to develop hydrogels with unique design at micro- and nano- scales to modulate stem cell differentiation, tissue regeneration and immunomodulation, with applications focus on musculoskeletal diseases. Her lab also harnesses biomaterials to create 3D cancer models with in vivo-mimicking phenotype and drug responses. Such 3D models could enable discovering novel druggable targets that would otherwise be missed using conventional 2D culture, and enable high-throughput drug screening with reduced cost and time than animal models. Prior to joining Stanford, Dr. Yang received her Ph.D. in Biomedical Engineering from Johns Hopkins University, and then completed a postdoctoral fellowship at MIT under Prof. Robert Langer. In recognition of her innovation, she has been recognized by numerous awards including Fellow of American Institute for Medical and Biological Engineering, MIT TR35 Global list honoree, National Science Foundation CAREER award, Young Investigator Award from Society for Biomaterials, Biomaterials Science Lectureship Award, Young Investigator award from Alliance for Cancer and Gene Therapy, Ellen Weaver Award by the Association for Women in Science, Baxter Faculty Scholar Award, the McCormick Faculty Award, Stanford Asian American Faculty Award, and the Basil O’Connor Starter Scholar Research Award.

Byeongmoon Jeong
(Ewha Womans University, Korea, Republic of)

Byeongmoon Jeong received his B.S. (1987) in the Department of Chemistry from Seoul National University, M.S (1989) from KAIST, and his Ph.D. (1999) in the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah. He worked at the Pacific Northwest National Laboratory, USA as a senior research scientist before joining Ewha Womans University in 2002. He has authored 150 international peer-reviewed papers and patents on stimuli-sensitive polymers; particularly related to biodegradable thermogels. His publications have been cited 17,000 times during the last decade. He received an Achievement Award in the Polymer Division of Korean Chemical Society (2010), Hanwha Polymer Award from Polymer Society of Korea (2021), Osstem Implant Biomaterials Grand Prize from Korean Society for Biomaterials (KSBM) (2022). His research concentrates on stimuli-sensitive hydrogels and their applications for drug delivery and tissue engineering. He is also serving as vice president of KSBM and editor in cheif of Biomaterials Research, an official journal of KSBM.

James Moon
(University of Michigan, Ann Arbor, USA)

Dr. James Moon is John Gideon Searle Professor in the Department of Pharmaceutical Sciences, Biomedical Engineering, and Chemical Engineering at the University of Michigan, Ann Arbor. His interdisciplinary research program aims to develop novel biomaterials-based strategies to advance fundamental understanding of the immune system, with the ultimate goal of improving patients’ lives with effective vaccines and immunotherapies. Dr. Moon has published over 120 research articles, including those published in Nature Materials, Nature Medicine, Nature Nanotechnology, Nature Biomedical Engineering, Nature Reviews Materials, and Science Translational Medicine. He has over 20 pending/approved U.S. and international patent applications, and his novel nano-vaccine delivery technologies have led to 3 new start-up companies (EVOQ Therapeutics, Saros Therapeutics, and Elicio Therapeutics). Dr. Moon is a fellow of BMES, AIBME, and CRS, and his contributions to the field has been recognized with numerous awards, including NSF CAREER Award and Samyang CRS Award. Dr. Moon received his bachelor’s degree from the University of California, Berkeley (2002), and his Ph.D. from Rice University (2008), and he completed his postdoctoral training at MIT. He joined the faculty of the University of Michigan in 2012.

James Wabby
(Regulatory Affairs (CoE), AbbVie, Inc, USA)

James is responsible for leading global regulatory affairs for AbbVie’s device and medicinal/device delivery portfolio providing the vision for the future of device at AbbVie and in the broader industry.
James has 22 years of experience in increasing regulatory compliance and regulatory affairs responsibilities within the GxP regulated environment pertaining to Medical Devices, Medicinal Delivery Platforms, Companion Diagnostics, Digital Medicine, and Combination Product areas. He regularly provides AbbVie therapeutic franchise units regulatory counsel and strategy to all aspects within the quality management system and regulatory affairs.
James is an internationally recognized leader as he is a member of various regulatory/quality work groups and is a speaker and keynote at various regulatory symposia. In addition, he is the Chair of the DIA Combination Products Committee, Chair of the ISPE Combination Products (CoP), and a moderator for various global regulatory panel discussions.

James holds a BSc. in Biology from Duquesne University, MHMS in Health Law and Policy from Duquesne University, Certificate in Health Law and Life Science Regulatory Compliance from Seton Hall University Law School - Center for Health & Pharmaceutical Law, and Certificate, RAPS Executive Development Program from Northwestern University - Kellogg School of Management.

Shelly Sakiyama-Elbert
(University of Washington, USA)

Shelly Sakiyama-Elbert, Ph.D. is the Vice Dean for Research and Graduate Education in the University of Washington School of Medicine and Professor of Bioengineering. She earned a S.B. in chemical engineering and biology from Massachusetts Institute of Technology, and a M.S. and Ph.D. from California Institute of Technology. She joined the faculty at Washington University in Biomedical Engineering in 2000 as an Assistant Professor, where she advanced to the position of the Joseph and Florence Farrow Professor of Biomedical Engineering and Vice Dean for Research in the School of Engineering. She served as Department Chair and Professor of Biomedical Engineering at the University of Texas at Austin from 2016- 2022.
Her research program focuses on developing biomaterials for drug delivery and cell transplantation for the treatment of peripheral nerve and spinal cord injury. She was Co-Director of the Center of Regenerative Medicine, as well as a member of the Institute of Materials Science and Engineering at Washington University. Her honors include Senior Scientist Award -TERMIS AM (2023), Fellow of the National Academy of Inventors (2017), Society for Biomaterials Clemson Award for Basic Research (2017), Outstanding Faculty Mentor from the WU Graduate Student Senate (2015), WU Distinguished Faculty Award (2013), and WU Dean’s Award for Excellence in Advising and Mentoring (2008). She was elected Fellow of the International College of Fellows in Biomaterials Science and Engineering in 2016, the American Association for the Advancement of Science (AAAS) in 2015, the Biomedical Engineering Society (BMES) in 2013, and the and the American Institute for Medical and Biological Engineering (AIMBE) in 2011.

Hala Zreiqat
(University of Sydney, Australia)

Hala Zreiqat, is a Payne-Scott Professor of biomedical engineering at The University of Sydney. The focus of her lab is on engineering functional synthetic biomaterials for use in regenerative medicine using cutting-edge materials, biological and nano techniques, and novel 3D-printing technologies.

Prof. Zreiqat’s contribution to regenerative medicine and orthopaedic research has led to a number of national and international awards, including being named a Member of the Order of Australia (2019), 2021-2022 Fulbright Senior Scholar; Laureate for the TAKREEM Foundation 2022 “Scientific & Technological Achievement”; the 2018 New South Wales Premier’s Woman of the Year, the King Abdullah II Order of Distinction of the Second Class (2018), Radcliffe Fellow at Harvard University (2016-2017); Eureka Prize winner for Innovative Use of Technology (2019); and University of Sydney Payne-Scott Professorial Distinction (2019). She is also a Fellow of the Australian Academy of Sciences (2021); the Australian Academy of Technology & Engineering (2020), the International Association of Advanced Materials (2022), the Royal Society of New South Wales (2019); Australian Academy of Health and Medical Sciences (2019), and the International Orthopaedic Research Society (2019). She is the past president of the Australian & New Zealand Orthopaedic Research Society. She was the Director of the Australian Research Council Training Centre for Innovative BioEngineering (2017-2022) and a National Health and Medical Research Council Senior Research Fellow (2006-2020). She is the Chair of the Council for Australian-Arab Relations (CAAR) (2020-2023); an Associate of the John A. Paulson School of Engineering and Applied Sciences at Harvard University and an Honorary Professor at Shanghai Jiao Tong University.

Prof. Zreiqat has authored over 180 peer-reviewed publications with over 10,000 citations. Her research in the field of musculoskeletal disorders and biomaterials research has led to four awarded and four provisional patents and more than $20.5M in competitive funding, including major grants from the National Health and Medical Research Council, Australian Research Council and the New South Wales Medical Devices Fund.
As well as her pioneering work in biomaterials development, Prof. Zreiqat is committed to improving opportunities for women and young scientists around the world. She is the founder and Chair of the BIOTech Futures, a science and engineering mentorship program for high school students.

Sung Yun Yang
(Chungnam National University, Korea, Republic of)

Sung Yun Yang received her B.S and M.S. from Ewha Womans University in 1991 and 1993, respectively. After serving in the Chemistry division at KRICT and KIST, in 1995 moved to USA for her doctoral degree in Polymer Chemistry and Engineering at Polytechnic University, New York University currently. In August of 2000, she moved to MIT as a postdoctoral researcher in the Department of Materials Science and Engineering. She worked in a biotech company for a year and returned to Korea in 2004 starting her professorship at Chungnam National University. Since 2004 she has been with CNU, is now a professor of Organic Materials Engineering. Along with her research and academic activity, she also served as a vice-president of the Center for Women in Science, Engineering and Technology to promote educational opportunity for woman engineers. Prof. Yang’s research interests include functional nanomaterials for energy, environmental sustainability, and biomedical application.

Maria Chatzinikolaidou
(Foundation for Research and Technology Hellas (FORTH) Institute of Electronic Structure and Laser 100, Greece)

Dr. Maria Chatzinikolaidou, FBSE, FTERM, is an Associate Professor of Biomaterials in Bioengineering and Head of the Laboratory for Biomaterials in Tissue Engineering at the Department of Materials Science and Technology at the University of Crete (https://www.materials.uoc.gr/el/general/personnel/mchatzin.html), and affiliated faculty member at Foundation for Research and Technology – Hellas (FORTH). Her research interests focus on the development of biomaterials and scaffolds for tissue engineering applications including bone, dental, cardiovascular, and the validation of their in vitro and in vivo biocompatibility, functionality and biomechanical characteristics.
Dr. Chatzinikolaidou is actively involved in several competitive national and international projects, is author of >90 publications in international peer-reviewed journals, 4 book chapters, >180 peer-reviewed conference abstracts, and inventor of 4 patents on osteoinductive implants. She was elected member of the Executive Board of the Hellenic Society for Biomaterials and served as vice president in the terms 2015-2018 and 2022-now. She served as chair of the 28th Conference of the European Society for Biomaterials (ESB 2017) held in Athens, and program chair of the TERMIS-EU 2019 conference held in Rhodes in Greece. She is a Fellow in Biomaterials Science and Engineering (FBSE, elected 2020) of the International Union of Societies for Biomaterials Science and Engineering (IUS-BSE) and International Fellow of Tissue Engineering and Regenerative Medicine (FTERM, elected 2023). Since 2022 she is member of the Nomination Committee of Tissue Engineering and Regenerative Medicine International Society (TERMIS) EU chapter. She is an editorial board member in Tissue Engineering, Frontiers in Bioengineering and Biotechnology, Regenerative Biomaterials, Frontiers in Bioengineering and Biotechnology, Journal of Materials Science Materials in Medicine etc. She teaches lectures on Biomaterials, Cell Biology and Biochemistry, and Tissue Engineering in undergraduate and graduate courses at the University of Crete and other Universities in Grece, and is currently supervisor of four PhD candidates and three Master’s students.

Sung-Tae Kim
(Seoul national university School of Dentistry, Korea, Republic of)

Dentist, Periodontist, Prosthodontist, Tenured professor in Seoul National University School of Dentistry and Seoul National University Dental Hospital

Seong-Ok Na
(GENOSS, Korea, Republic of)

I work as a researcher at the R&D center of Genoss, a medical device manufacturing company.
While in charge of developing implantable medical devices, she led and participated in several projects for industrialization of biocompatible medical devices.

Paul Delrot
(Readily3D, Switzerland)

Paul co-invented the volumetric bioprinting technology at the end of his PhD studies at EPFL in 2017. After transferring what was a lab experiment into a standalone and user-friendly 3D printer, Paul co-founded Readily3D in 2020. Since then, Paul has focused on demonstrating the wide range of applications enabled by volumetric bioprinting while leading product development at Readily3D.

Terance Hart
(Maverick Biosciences, United Kingdom)

Dr Hart worked for over 30 years in Pharmaceutical Research for global companies such as Sanofi-Genzyme and Novartis as well as in many different Biotech companies, where he led teams in their discovery of new pharmaceuticals.

During the last 14 years he was for 10 years Chief Scientific Officer for Geistlich Pharma in Switzerland, where the R&D team brought through important, innovative collagen based products to the dental and tissue regeneration market, including Mucograft, Fibro-Gide and Derma-Gide. Currently he is a Scientific Advisor for Maverick Bioscience and a member of their Scientific Advisory Board.

Wei Sun
(Drexel University and Tsinghua University, China)

Dr. Sun Wei, a young researcher at State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University. He obtained his Ph.D. from Tongji University in 2019 under the supervision of Professor Wu Guangming. He joined Donghua University in October 2019 and his main research areas include the design and construction of functional conductive elastic materials, and 3D printing of biomaterials for medical applications. He has published a total of 25 SCI papers, with 15 papers as the first author/corresponding author in international academic journals such as ACS Nano, Theranostics, J. Mater. Chem. A, Adv. Electron. Mater., etc. One of his papers has been highly cited according to ESI. He has filed 7 invention patents in China, 5 of which have been granted. He is the principal investigator for 1 National Natural Science Foundation of China (NSFC) Young Scientist Fund, 2 sub-projects of the Ministry of Science and Technology's key research and development program, and 1 collaborative project with industry.

Jinye Wang
(Shanghai Jiao Tong University, China)

Prof. Jin-Ye Wang, Ph.D (Tohoku University, Japan, 1992).
Professor of Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (2000-2009); Professor of Biomedical Engineering, Shanghai Jiao Tong University (2009-).
Published 140 papers and 6 books (chapters); authorized 20 patents; invited speaker of European Conference on Biomaterials, Pacifichem et al.; awarded Hundred Talent Program of the Chinese Academy of Sciences (1999), Life Sciences Prize from Meiji Dairies Corporation (2008) et al.
Research interests: 3D Bioprinting, Tissue Engineering, Controlled Release, Biomimetic Materials and Biointerfaces.

Selected Publications (2020-)：
1. Lin, Y.F., Yu, J.W., Zhang, Y.B., Hayat, H., Liu, C., Huang, X.Y., Lin, H.D.* and Wang, J.Y.* 4D Printed Tri-segment Nerve Conduit Using Zein Gel as the Ink for Repair of Rat Sciatic Nerve Large Defect. (2023) Biomaterial Advance, 151, 213473. 10.1016/j.bioadv.2023.213473
2. Hayat, H., Liu, C., Raza, A., Jingli Hou, J., Jia, C. and Wang, J.Y.* In vitro/in vivo identification of zein degraded peptides using HPLC-MS/MS and their safety evaluation. (2023) Biomedical Materials, 18, 025007. https://iopscience.iop.org/article/10.1088/1748-605X/acb411
3. Zhang,Y., Xue, Y., Ogawa, T., Wada, S. and Wang, J.Y.* 3D Printed Alginate Hydrogels with Stiffness-Gradient Structure in a Carbomer Supporting Bath by Controlled Ca2+ Diffusion. (2023) ACS Applied Engineering Materials, 1, 802-812. https://pubs.acs.org/doi/10.1021/acsaenm.2c00218
4. Jia, C.W., Zhang, Y.C., Wang, Y.Y., Gao, J.N., Raza, A., Ogawa, T., Wada, S., Xie, D. and Wang, J.Y.* Positively charged and neutral drug-loaded liposomes as the aerosolized formulations for the efficacy assessment of tumor metastases to lungs. (2023) Journal of Drug Delivery Science and Technology, 80, 104081. https://www.sciencedirect.com/science/article/pii/S1773224722009923
5. Zhang, Y.B., Raza, A., Xue, Y.Q., Yang, G.G., Hayat, U., Yu, J.W., Liu, C., Wang, H.J. and Wang, J.Y.* Water-responsive 4D printing based on self-assembly of hydrophobic protein “Zein” for the control of degradation rate and drug release. (2023) Bioactive Materials, 23, 343-352.
6. Raza, A., Zhang, Y.B., Uzma, H., Song, J.L., Shen, N.A., Chao, Y., Wang, H.J.* and Wang, J.Y.* Injectable zein gel with in situ self-assembly as hemostatic material. (2023) Biomaterial Advance, 145, 213225.
7. Xue, Y.Q., Zhang, Y.C., Zhang, Y.B. and Wang, J.Y.* Zein-based 3D Vascularized Scaffolds with Tunable Porosity for 3D Cell Culture and Drug Delivery. (2023) Biomedical Engineering Advances,5, 100059. https://www.sciencedirect.com/science/article/pii/S2667099222000354
8. Raza, A., Uzma, H., Zhang, X.H. and Wang, J.Y.* Self-assembled zein organogels as in situ forming implant drug delivery system and 3D printing ink. (2022) International Journal of Pharmaceutics, 627, 122206.
9. Li, J., Zhou, Y., Xu, J., Gao, F., Si, Q., Wang, J.Y., Zhang, F. and Wang, L.P.* Water-Soluble and Degradable Gelatin/Polyaniline Assemblies with High Photothermal Conversion Efficiency for pH Switchable Precise Photothermal Therapy. （2022）ACS Applied Materials & Interfaces, 14, 52670-52683.
10. Liu, C., Uzma, H., Raza, A., Jia, C.W. and Wang, J.Y.* Zein-based injectable biomaterial and angiogenic activity through peptides produced by enzymatic degradation. (2022) Journal of Drug Delivery Science and Technology, 78, 103937.
11. Zhang, Y.B., Wang, H.J., Raza, A., Liu, C., Yu, J.W. and and Wang, J.Y.* Preparation and evaluation of chitosan/polyvinylpyrrolidone/zein composite hemostatic sponges. (2022) International Journal of Biological Macromolecules. 205, 110-117.
12. Uzma, H., Raza, A., Bilal, M.N. lqbal, H.M.N* and Wang, J.Y.* Biodegradable polymeric conduits: Platform materials for guided nerve regeneration and vascular tissue engineering. (2022) Journal of Drug Delivery Science and Technology, 67, 103014.
13. Liu, C., Yang, H., Shen, N.A., Li, J.H., Chen, Y.S. and Wang, J.Y.* Improvement of Mechanical Properties of Zein Porous Scaffold by Quenching/Electrospun Fiber Reinforcement. (2021) Biomedical Materials, 16, 065016.
14. Wang, H.J.*, Mao, Q.Y., Feng, G., Liu, C., Yang, M.Z., Hao, M.F., Meng, Z.F., Li, S.M., Zhang, Y.P. and Wang, J.Y.* 3D printing of multi-functional artificial conduits against acute thrombosis and clinical infection. (2022) Composites Part B-Engineering, 230, 109497.
15. Yu, J.W., Wang, G.W., Lin, Y.F., Song, J.L., Hayat, U., Liu, C., Raza, A., Wu, W.F., Lin, H.D. and Wang, J.Y.* Zein-induced immune response and modulation by size, pore structure and drug-loading: Application for sciatic nerve regeneration. (2022) Acta Biomaterialia, 140, 289-301.
16. Wang, L.P., Wang, H.J., Hou, X.S., Raza A. and Wang, J.Y.* Preparation of stretchable composite film and its application in skin burn repair. (2021) Journal of the Mechanical Behavior of Biomedical Materials, 113, 104114.
17. Shen, N.A., Zhang, Y. and Wang, J.Y.* A parallel plate flow chamber device for evaluation of cell retention of electrospun zein fiber film under steady shear. (2021) Journal of Shanghai Jiaotong University (Sci), 26 (1), 69-75.
18. Shen, N.A., Zhang, Y. and Wang, J.Y.* Effects of the micro/nanostructure of electrospun zein fibres on cells in a fluid environment. (2021) Materials Science and Engineering C, 122, 111900.
19. Hou X.S., Zhou Y., Liu Y.J., Wang L.P.*, Wang J.Y. Coaxial electrospun flexible PANI//PU fibers as highly sensitive pH wearable sensor. (2020) Journal of Material Science, 55(33), 16033-16047.
20. Raza, A., Uzma, H., Bilal, M., lqbal, H.M.N* and Wang, J.Y.* Zein-based micro- and nano- constructs and biologically therapeutic cues with multi-functionalities for oral drug delivery systems. (2020) Journal of Drug Delivery Science and Technology, 58, 101818.
21. Uzma, H, Raza, A. and Wang, J.Y.* Preparation of Zein/PVP based conduits with tunable degradation. (2020) Polymer Degradation and Stability, 181, 109303.
22. Raza, A., Uzma, H., Wang, H.J. and Wang, J.Y.* Preparation and evaluation of captopril loaded gastro-retentive zein based porous floating tablets. (2020) International Journal of Pharmaceutics, 579, 119185.
23. Uzma, H., Raza, A., Wang, H.J.* and Wang, J.Y.* Preparation of ciprofloxacin loaded zein conduits with good mechanical properties and antibacterial activity. (2020) Materials Science and Engineering C, 111, 110766.

Jian Yang
(Westlake University, China)

Dr. Jian Yang is currently a Chair Professor in Biomaterials and Regenerative Engineering, the chair of Biomedical Engineering Program, and an Associate Vice President at the Westlake University. Prior to Westlake, he was a Professor of Biomedical Engineering and Dorothy Foehr Huck and J. Lloyd Huck Chair in Regenerative Engineering at the Pennsylvania State University. Dr. Yang is known for his pioneering contribution on citrate chemistry and biology for the development and applications of citrate-based biomaterials. He was a recipient of NSF CAREER Award (2010), Outstanding Young Engineering Faculty Award at UTA (2011), PSEAS Outstanding Research Award at Penn State (2018), and BMES Wallace H. Coulter Award for Healthcare Innovation Award (2023). Dr. Yang is an elected Fellow of American Institute of Medical and Biological Engineering (AIMBE, 2016), the National Academy of Inventors (NAI, 2018), the Biomedical Engineering Society (BMES, 2020), the American Association for the Advancement of Science (AAAS, 2021), and the International Academy of Medical and Biological Engineering (IAMBE, 2023). Dr. Yang is the Co-Editor-in-Chief of “Bioactive Materials”, and an Associate Editor of “Science Advances”. Dr. Yang is a co-founder and the Past-President of Chinese Association for Biomaterials (CAB) and the recipient of 2023 CAB Distinguished Leadership and Service Award. Dr. Yang co-founded a medical device company, Aleo BME, Inc. and is also serving on the Scientific Advisory Board of Acuitive Technologies, LLC.

William Wagner
(University of Pittsburgh, USA)

Professor William R. Wagner is a Distinguished Professor of Surgery, Chemical Engineering, and Bioengineering at the University of Pittsburgh and the Founding Editor and Editor-in-Chief of one of the leading biomaterials journals, Acta Biomaterialia. He holds a B.S. (Johns Hopkins Univ.) and Ph.D. (Univ. of Texas) in chemical engineering. Professor Wagner currently serves as president of the Society for Biomaterials (US) and is a past-president of the American Society for Artificial Internal Organs (ASAIO) and past chairman of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) Americas region. He is a fellow and former vice president of the American Institute for Medical and Biological Engineering (AIMBE) and has also been elected a fellow of the Biomedical Engineering Society, the International Union of Societies for Biomaterials Science and Engineering, TERMIS, the International Academy of Medical and Biological Engineering (IAMBE) and the American Heart Association. He has been selected to the “Scientific American 50”, the magazine’s annual list recognizing leaders in science and technology from the research, business and policy fields. His research has generated numerous patents (50 issued to date) and patent filings that have resulted in licensing activity, the formation of three companies, one of which initiated two clinical trials. Transfer of his group’s intellectual property has been recognized with University of Pittsburgh Innovator Awards in 2007, 2008, 2009, 2010, 2014, 2017 and 2018. Some of his awards include the Society for Biomaterials Clemson Award for Applied Research, the Chancellor’s Distinguished Research Award from the University of Pittsburgh, and the Senior Investigator Award from TERMIS-Americas. In 2017 he was inducted as a fellow of the National Academy of Inventors and in 2018 he was named Inventor of the Year by the Pittsburgh Intellectual Property Law Association. In 2019 Dr. Wagner was promoted to the rank of Distinguished Professor, the highest recognition available to University of Pittsburgh faculty. In 2020 the 4th edition of the best-selling biomaterials textbook, “Biomaterials Science” was published with Dr. Wagner taking over the lead editor role and in partnership with a new generation editorial team. He was also named by Pittsburgh Business Times to its “Power 100” list (“people who have defined and are redefining the region, and who are leading and shaping their industries”). Dr. Wagner recently received the Founder’s Award from the Society for Biomaterials (2021) and the Global Biomaterials Leadership Award from the Chinese Association for Biomaterials (2023). Dr. Wagner also was recently awarded the Marlin Mickle Outstanding Innovator Award through the University of Pittsburgh’s Innovation Institute for extraordinary commitment to innovation commercialization. Dr. Wagner’s research interests are in cardiovascular engineering with projects that address medical device biocompatibility and design, biomaterial development, and tissue engineering.

Shaoyi Jiang
(Cornell University, USA)

Shaoyi Jiang joined the Meinig School of Biomedical Engineering at Cornell as the Robert Langer ’70 Family and Friends Professor in June 2020. Before Cornell, he was the Boeing-Roundhill Professor of Engineering in the Department of Chemical Engineering and an adjunct professor of Bioengineering at the University of Washington, Seattle. He received his Ph.D. degree in chemical engineering from Cornell University in 1993. He was a postdoctoral fellow at the University of California, Berkeley between 1993 and 1994 and a research fellow at California Institute of Technology between 1994 and 1996 both in chemistry. He is currently a fellow of the American Association for the Advancement of Science (AAAS), a fellow of the American Institute of Chemical Engineers (AIChE), a fellow of the American Institute for Medical and Biological Engineering (AIMBE), an executive editor for Langmuir and an associate editor for Science Advances. He received the Braskem Award for Excellence in Materials Engineering and Science, AIChE (2017). His research focuses on biomaterials, particularly highly biocompatible and environmentally benign zwitterionic-based materials for biomedical and engineering applications.

Xing-Jie Liang
(National Center for Nanoscience and Technology of China, China)

Xing-Jie LIANG, Ph.D.
Member of Academia Europaea
Fellow of American Institute of Medical and Biological Engineering
Chief Professor, University of Chinese Academy of Sciences
CAS Center for Excellence in Nanoscience
CAS Key Lab of Bioeffects of Nanomaterials and Nanosafety
National Center for Nanoscience and Technology of China
E-mail： liangxj@nanoctr.cn
Tel: +86-010-82545569 Fax: +86-010-62656765
ORCID: 0000-0002-4793-1705


Dr. Xing-Jie Liang got Ph.D at National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences. He finished his postdoc with Dr. Michael M. Gottesman, member of NAS and Deputy Director of NIH, for 5 years at Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health. Then, he worked as a Research Fellow at Surgical Neurology Branch, NINDS, NIH. Dr. Liang currently is a principal investigator at Center for Excellence in Nanoscience, Chinese Academy of Sciences. He as previous president of Chinese Association of Nanobiology is the Member of Academia Europaea (2023) and the elected Fellow of American Institute for Medical and Biological Engineering (AIMBE, 2020) and Faculty Member of F1000 Research (Pharmacology & Drug Delivery, 2012) and Hall of Fame (Advanced Materials, 2023). Dr. Liang has successfully developed “Injectable Nanomicelle Powder with Irinotecan” approved with CFDA and transferred NDA to pharmaceutical industry for clinical trials.

His group has published over 300 peer-reviewed articles, H-index > 100. His research interests are in elucidating mechanisms to improve drugability and nanomedicinal bioavailability by nanotechnology in vitro and in vivo, and novel strategies to increase therapeutic efficiency on cancers and infective diseases. Developing drug delivery strategies for prevention/circumvent of clinical adaptive treatment tolerance (ATT) are current programs ongoing in Professor Liang's lab based on understanding of basic physio-chemical and biological processes of nanomedicine.

Juyong Yoon
(Ewha Womans University, Korea, Republic of)

Juyoung Yoon is a distinguished professor at the Department of Chemistry and Nanoscience, Ewha Womans University. He received his PhD (1994) from Ohio State University and conducted his postdoctoral work at UCLA and Scripps Research Institute. His research interests include investigations of fluorescent imaging probes, activatable photosensitizers, phototherapy and organic functional materials. His h-index is 124 and was listed as a highly cited researcher in chemistry for 2014-2023.

Guixue Wang
(Bioengineering College of Chongqing University, China)

Dr. Guixue Wang is a Distinguished Professor of Biomedical Engineering and former Dean of the College of Bioengineering, Chongqing University, China. He also worked as the Principal Investigator of JinFeng Laboratory at Chongqing. He has also served as a Deputy Director of the Academic Committee of Chongqing University Health Science Center. He is a director of the Key Laboratory of Biorheology Science and Technology of the Chinese Ministry of Education, a founding director of the Public Experiment Center of National Biological Industrialization Base at Chongqing, and a founding director of the National Local Joint Engineering Laboratory for Vascular Implants of China, a founding director of Chongqing Engineering Laboratory for Vascular Implants of China. He serves as an Associate Editor of Research (IF:11), Deputy Editor-in-Chief of Molecular & Cellular Biomechanics, an Associate Editor of Journal of Medical and Biological Engineering, and an Editorial Member of Biomedical Materials. He also serves as a reviewer for 50 international journals.

He has served as multiple Chairpersons: including Branch of Atherosclerosis of the Chinese Society of Pathophysiology (2021.05-) and Materiobiomechanics Branch of the Chinese Society for Biomaterials (2022.12-), Honorary Chairperson: Vascular Branch of the Chinese Society of Anatomy (2023.12-), Executive Member of the Council: Interventional Treatment of Cardiac and Brain Diseases Branch of the Chinese Medical Device Industry Association (2017-), Cardiovascular Biomaterials Branch of the Chinese Society for Biomaterials (2015-), Chinese Branch of International Society of Atherosclerosis (2015-), Holistic Integrative Medicine and Engineering Alliance (2018-); Member of the Council: Chinese Society of Biomedical Engineering (2015-1019), Chinese Society for Biomaterials (2012-), Biomechanics Branch of the Chinese Society of Mechanics/Chinese Society of Biomedical Engineering (2015-), and Life Member: including World Association for Chinese Biomedical Engineers (2016-) and International Chinese Musculoskeletal Research Society (2019-).

His areas of research interest include vascular biomechanics and mechanobiology, tissue repair materials and minimally invasive interventional medical devices. He has led more than 20 national and provincial-level key scientific research projects; collaboratively published more than 300 SCI/EI indexed papers in Nat Neurosci, J Biomech, Adv Sci, Bioact Mater, Biomaterials and other academic journals; authorized more than 60 domestic and international patents; and won 6 provincial and ministerial science and technology and teaching achievement awards, 3 national industry associations and societies awards.

He was selected as the Elsevier “Most Cited Chinese Researchers in Biomedical Engineering” in 2019, 2020, 2021, 2022 and 2023; World's Top 2% Scientists in 2023; and a Fellow of International Union of Societies for Biomaterials Science and Engineering (FBSE) in 2023.

Nicholas A. Peppas
(The University of Texas at Austin, USA)

Professor Nicholas A. Peppas is a chemical engineer, materials scientist, and nanotechnologist whose research contributions, innovations, inventions have led to 20 chemical/medical/pharmaceutical products.
Peppas is an elected member of the US-National Academy of Engineering, US- National Academy of Medicine, American Academy of Arts and Sciences, Academy of Inventors, Academia Europaea, Canadian Engineering Academy, Indian National Engineering Academy, Chinese Academy of Engineering, Korean Academy of Science Technology, National Academy of France, Royal Academy of Spain, Academy of Athens, Greece, Academy of Romanian Scientists, and Academy of Texas. He has served as a Visiting Professor in the Universities of Geneva, Paris-Sud, Santiago de Compostela. Madrid, Lisbon, Parma, Pavia, Napoli, Hecettepe/Ankara, Athens, Berlin, Hebrew University/Jerusalem, Hoshi University/Tokyo, Nanyang University/Singapore, Sichuan University, Peking Medical College. Peppas is a distinguished professor in Chemical Engineering, Biomedical Engineering, Pediatrics, Surgery and Pharmacy, and a member of the Texas Materials Institute at the University of Texas at Austin. His group has set the fundamentals of flow and transport phenomena in numerous medical problems, based on the principles of Engineering Science. He has numerous books, 1,800 publications and is cited in more than 193,000 references (H=202). Honored by 170 Awards including NAE Founders Award, NAM Adam Yarmolinsky, Pharmaceutical Global Leader Award, and the Biomaterials Global Impact Awards. Peppas holds a D.Eng. from NTU Athens, a ScD. from MIT and is the recipient of 13 honorary doctorates and professorships from France, Spain, Italy, Belgium, Greece, Slovenia, Romania, Israel and China. Editor of Regenerative Biomaterials (Oxford) and President on the International Sigma Xi organization. He actively works to diversify program interests, take an active role towards increasing the number of young members, and actively promote the election and participation of a diverse and inclusive group of scientists.

Andrés J. García
(Andrés J. García, USA)

Andrés J. García is the Executive Director of the Petit Institute for Bioengineering and Bioscience and Regents’ Professor at the Georgia Institute of Technology. Dr. García’s research program integrates innovative engineering, materials science, and cell biology concepts and technologies to create cell-instructive biomaterials for regenerative medicine and generate new knowledge in mechanobiology. This cross-disciplinary effort has resulted in new biomaterial platforms that elicit targeted cellular responses and tissue repair in various biomedical applications, innovative technologies to study and exploit cell adhesive interactions, and new mechanistic insights into the interplay of mechanics and cell biology. In addition, his research has generated intellectual property and licensing agreements with start-up and multi-national companies. He is a co-founder of 3 start-up companies (CellectCell, CorAmi Therapeutics, iTolerance). He has received several distinctions, including the NSF CAREER Award; the Young Investigator Award, the Clemson Award for Basic Science, and the Founders Award from the Society for Biomaterials; the International Award from the European Society for Biomaterials; and Georgia Tech’s Outstanding Interdisciplinary Activities Award and the Class of 1934 Distinguished Professor Award. He is an elected Fellow of Biomaterials Science and Engineering (by the International Union of Societies of Biomaterials Science and Engineering), Fellow of the American Association for the Advancement of Science, Fellow of the American Society of Mechanical Engineers, and Fellow of the American Institute for Medical and Biological Engineering. He served as President for the Society for Biomaterials in 2018-2019. He is an elected member of the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors.

Pamela Habibovic
(Maastricht University, Netherlands)

Pamela Habibovic is Professor of Inorganic Biomaterials at Maastricht University, the Netherlands. Since February 2022, she holds the position of Rector of Maastricht University. Habibovic was a founding partner of MERLN Institute for Technology-Inspired Regenerative Medicine, established in 2014, and Chair of MERLN’s Department for Instructive Biomaterials Engineering. Between 2019 and 2022, she was the Scientific Director of MERLN.

Initially trained as a chemical engineer, in 2005, Habibovic obtained a PhD degree from the University of Twente, the Netherlands on the topic of materials for biomedical applications. Following postdoctoral research at Children’s Hospital Boston and McGill University, in 2008, she started her research group at the University of Twente. In 2014, she moved to Maastricht University. The main focus of her research is on synthetic bone graft substitutes, bioinorganics, nanomaterials for theranostics in regenerative medicine and high-throughput approaches in biomaterials research. For her research she received prestigious Veni, Vidi, Aspasia and Gravitation grants of the Dutch Research Council NWO, among other external research funds. She served as the President of the European Society for Biomaterials between 2017 and 2021 and as an Associate Editor of the RSC journal Biomaterials Science between 2019 and 2022. In 2017, she received the Jean Leray Award of the European Society for Biomaterials and in 2021 she was elected a Fellow of the Royal Society of Chemistry. She has published over 100 peer-review articles on the topic of biomaterials and regenerative medicine.

Anthony Weiss
(University of Sydney, Australia)

Professor Tony Weiss is the President of TERMIS, and McCaughey Chair in Biochemistry, Professor of Biochemistry & Molecular Biotechnology, Director of the Charles Perkins Centre’s Tissue Engineering & Regenerative Medicine Laboratory and NHMRC Leadership Fellow at the University of Sydney. His research on the elastic protein tropoelastin underpins novel applications in wound repair. He is a serial inventor on 172 granted patents in 23 families, and founded Elastagen which was sold in one of the largest national healthcare transactions. He was awarded the Order of Australia, and is a Fellow of the Australian Academy of Technology & Engineering, Royal Society of Chemistry, Royal Australian Chemical Institute, Royal Society of NSW, American Institute for Medical & Biological Engineering, and the US National Academy of Inventors. He is a highly decorated innovator, with multiple innovation medals from the RACI, ATSE’s Clunies Ross Medal, the Eureka Prize for Innovation in Medical Research, NSW Premier’s Prize for Science & Engineering Leadership in Innovation, and the top innovation prize in Australia: the Prime Minister’s Prize for Innovation.

John Fisher
(University of Maryland, USA)

Dr. John P. Fisher is the MPower Professor, Distinguished-Scholar Teacher, Fischell Family Distinguished Professor, and Department Chair in the Fischell Department of Bioengineering at the University of Maryland. Dr. Fisher is also the Director of the Center for Engineering Complex Tissue (CECT), which aims to create a broad community focusing on 3D printing and bioprinting for regenerative medicine applications. As the Director of the Tissue Engineering and Biomaterials Laboratory, Dr. Fisher’s group investigates biomaterials, stem cells, bioprinting, and bioreactors for regenerating lost tissues, particularly bone, cartilage, and cardiovascular tissues. Dr. Fisher’s laboratory has published over 225 articles, book chapters, editorials, and proceedings (16,000+ citations / 72 h-index) and delivered over 400 invited and contributed presentations, with support from NIH, NSF, FDA, NIST, DoD, and other institutions. Dr. Fisher has been elected Fellow of the American Institute for Medical and Biological Engineering (2012), the Biomedical Engineering Society (2016), the International Academy of Medical and Biological Engineering (2020), and the International Union of Societies for Biomaterials Science and Engineering (2024). In 2023, Dr. Fisher was elected Chair of the Council of Chairs (CoC), an assembly of the 150+ biomedical engineering / bioengineering department chairs throughout the United States and beyond. Dr. Fisher will serve as Chair of the CoC in 2025.

Yunbing Wang
(Sichuan University, China)

Prof. Yunbing Wang is the Director of National Engineering Research Center for Biomaterials of China, Dean of College of Biomedical Engineering of Sichuan University. His work has been focused on the research and development study of in-situ cardiovascular tissue repair and regeneration based on bioresorbable polymeric materials and devices with near 300 scientific papers published, more than 400 patents granted/issued, and more than 100 invited presentations made.

His research has been transformed into a variety of commercialized cardiovascular implantable devices and saved thousands of lives worldwide, including the world's first commercialized bioabsorbable occluder for the treatment of congenital heart disease which provides temporary occlusion and induces in situ tissue regeneration, as well as the first commercialized bioabsorbable vascular stent. He developed a self-expanding transcatheter pulmonary valve through collaboration with company with approval both in Europe and China. He was the First prize winner of the 2021 Technology Invention Award of the Ministry of Education of China.

Tetsuji Yamaoka
(National Cerebral and Cardiovascular Research Institute, Japan)

Tetsuji YAMAOKA, Ph.D. FBSE
-President of Japanese Society for Biomaterials
-Professor, Department of Clinical Engineering, Faculty of Health Sciences, Komatsu University,
-Visiting Director, National Cerebral and Cardiovascular Center Research Institute

EDUCATION
-1991 Ph.D., Polymer Chemistry, Kyoto University, Kyoto, JAPAN, Distribution and Half-life of Polymeric Substances Injected into the Body
-1988 B.S., Polymer Chemistry, Kyoto University, Kyoto, JAPAN

DISTINCTIONS
-1995 Award for Encouragement of Research in Polymer Science, The Society of Polymer Science, Japan
-2002 The Award for Young Investigator of Japanese Society for Biomaterials
-2010 The Award of Japanese Society for Biomaterials
-2011 The Award of the Society of Fiber Science and Technology Japan
-2011 IAAM Medal-2001 (International Association of Advanced Materials)

EXPERIENCE
-2023-present: Professor, Department of Clinical Engineering, Faculty of Health Sciences, Komatsu University
-2004-present: Director/Visiting Director, Department of Biomedical Engineering, Advanced Medical Engineering Center, National Cardiovascular Center Research Institute
-2002-2004: Associate Professor, Department of Polymer Science and Engineering, Kyoto Institute of Technology, Kyoto, Japan
-1995-2002: Lecturer, Department of Polymer Science and Engineering, Kyoto Institute of Technology, Kyoto, Japan
-1996-1997: Visiting Scientist, Department of Polymer Science and Engineering, University of Massachusetts at Amherst, MA,
-1992-1995: Assistant Professor, Department of Polymer Science and Engineering, Kyoto Institute of Technology, Kyoto, Japan
-1991-1992: Research Fellow, National Cardiovascular Center, Osaka, Japan

MEMBERSHIP IN PROFESSIONAL SOCIETY
-President of Japanese Society for Biomaterials
-Fellow of Biomaterials Science and Engineering (FBSE)
-Councilor: The Japanese Society of Gene Design and Delivery, The Society of Life Support Technology, Japanese Society for Artificial Organs, The Japanese Society of Drug Delivery System
Editorial Board: Journal of Artificial Organs
-Member: ACS, SFB, CRS, The Chemical Society of Japan, The Society of Polymer Science Japan, The Society of Fiber Science and Technology Japan, The Japanese Society for Regenerative Medicine

RUNNING SENTENCE
Prof. Tetsuji YAMAOKA is Professor of Department of Clinical Engineering of Komatsu-University (Ishikawa, Japan) and director of Department of Biomedical Engineering of National Cerebral and Cardiovascular Center Research Institute (Osaka, Japan). He is president of Japanese Society for Biomaterials (JSB) from 2020, former president of Asian Biomaterials Federation (2019-2021), and Japanese delegate for the International Union of Societies for Biomaterials Science and Engineering (IUS-BSE) (2008-2020). He hosted 40th anniversary annual meeting of JSB in Kobe in 2018, Joint Symposium of JSB and Society for Biomaterials (SFB) in Hawaii, and Asia Biomaterials Congress in conjunction with 43rd annual meeting of JSB in Nagoya in 2021. He has published more than 320 publications, review, books, and patent and received the Award of Japanese Society for Biomaterials (2010), the Award of the Society of Fiber Science and Technology Japan (2011), and so on. His recent research interest is especially focusing on both of the bio-derived and synthetic biodegradable materials, especially acellular tissue as cardiovascular biomaterials.

Molly Stevens
(Imperial College London, United Kingdom)

Prof Molly Stevens FREng FRS is John Black Professor of Bionanoscience at the University of Oxford and also holds part-time professorships at Imperial College London and the Karolinska Institute.
She graduated with a First-Class Honours BPharm degree from Bath University in 1995 and a PhD from the University of Nottingham in 2001. After postdoctoral research in the Langer Lab at MIT, she joined Imperial College London in 2004 as a lecturer and was promoted to Professor in 2008 as one of the youngest Professors ever in the history of the institution.
Molly’s multidisciplinary research balances the investigation of fundamental science with the development of technology to address some of the major healthcare challenges. She is a serial entrepreneur and the founder of several companies in the diagnostics, advanced therapeutics and regenerative medicine space. Her work has been instrumental in elucidating the bio-material interfaces. She has created a broad portfolio of designer biomaterials for applications in disease diagnostics and regenerative medicine. Her substantial body of work influences research groups around the world (>430 publications, h-index 104, >44k citations, 2018, 2021 and 2022 Clarivate Analytics Highly Cited Researcher in Cross-Field research).
Molly holds numerous leadership positions including Director of the UK Regenerative Medicine Platform "Smart Acellular Materials" Hub, Deputy Director of the EPSRC IRC in Early-Warning Sensing Systems for Infectious Diseases and Scientist Trustee of the National Gallery. She is Fellow of the Royal Society and the Royal Academy of Engineering (UK), Foreign Member of the National Academy of Engineering (USA) and International Honorary Member of the American Academy of Arts and Sciences.

Takao Hanawa
(Tokyo Medical and Dental University, Japan)

Dr. Takao HANAWA is a Council Member of the Science Council of Japan since 2020 and a Fellow of The International Union of Societies for Biomaterials Science and Engineering (IUSBS). He has also positions as Professor of Division of Materials and Manufacturing Science, Graduate School of Engineering, Osaka University and Professor of Center for Advanced Medical Engineering Research and Development, Kobe University. He was Professor of Department of Metallic Biomaterials, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Japan, since 2004 and has retired 2023. He was once presidents of the Japanese Society for Biomaterials and Japanese Society for Dental Materials and Devices. He received his Ph.D. from Hokkaido University at 1989 and Tohoku University at 1998. He has experienced as Assistant Professor in Hokkaido University, Associate Professor in Tokushima University, and Deputy-in-General of Biomaterials Research Center, National Institute for Materials Science (NIMS). He has developed new metallic biomaterials such as zirconium alloys showing low magnetic susceptibility to decrease MRI artifact and several surface treatment techniques. Recently micro-arc oxidation process to add dual-function to titanium and nano-topography to accelerate the differentiation of stem cells by femto-second laser. In addition, interface reaction between titanium and living tissues is a life work of him, then near recently principle of the excellent biocompatibility of titanium has been elucidated from the viewpoint of electronic band structure of the passive film. He has published 312 original research papers and 106 review papers. His Scopus h-index is 51 at present.

Diego Mantovani
(Laval University, Canada)

Professor in biomaterials, scientist in regenerative medicine, holder of the Canada Research Chair Tieur I in biomaterials and bioengineering for the innovation in surgery, Diego Mantovani is en expert in nanocoatings, biodegradable metals and 3D cell culture for advanced in vitro tests alternative to in vivo. With his team, he carried out R&D&I projects often in collaboration with companies to unravel how sciences and engineering can improve the patient quality of life of Humans, and to develop new processes for improving the clinical performances of commercial devices, as well as exploring new strategies for tomorrow's clinical therapies. Focus is on cardiac, peripheral, cerebral, dental and parenchymal tissue. The Lab is based at ULaval, in the beatiful nordic city of Quebec, labelled UNESCO treasure, in the French-living part of Canada. He was elected Fellow of the International Union of Societies of Biomaterials since 2012, of the American Society for Materials Intl since 2016, the American Institute of Medical Biological Engineering since 2019, and of the Canadian Academy of Engineering since 2020. He was executive Co-Chair of the 10th World Biomaterials Congress, held in Montréal, Canada, in 2016, May.

Paula T. Hammond
(Massachusetts Institute of Technology, USA)

Professor Paula T. Hammond is Institute Professor at the Massachusetts Institute of Technology and a member of MIT’s Koch Institute for Integrative Cancer Research. She was Head of the Department of Chemical Engineering from 2015 to 2023, and is Vice Provost for Faculty as of January 2024.
The core of her work is the use of electrostatics and other complementary interactions to generate functional materials with highly controlled architecture. Her research in nanomedicine encompasses the development of new biomaterials to enable drug delivery from surfaces with spatio-temporal control. She also investigates novel responsive polymer architectures for targeted nanoparticle drug and gene delivery. The newest developments from her lab offer a promising approach to the delivery of proteins and messenger RNA (mRNA) using electrostatic assembly as a means of modifying surfaces, nanoparticles and lipid complexes for targeted systemic delivery, opening potential for vaccines and immunotherapies.


Professor Paula Hammond was elected into the National Academy of Science in 2019, the National Academy of Engineering in 2017, the National Academy of Medicine in 2016, and the 2013 Class of the American Academy of Arts and Sciences. She is also a member of the National Academy of Inventors. She received the American Institute of Chemical Engineers (AIChE) Margaret H. Rousseau Pioneer Award for Lifetime Achievement by a Woman Chemical Engineer in 2019 and gave the Materials Research Society (MRS) David Turnbull Lectureship, 2019. Professor Hammond has published over 330 papers, and over 20 patent applications. She is the co-founder and member of the Scientific Advisory Board of LayerBio, Inc., a member of the Scientific Advisory Board of Moderna Therapeutics and a member of the Board of Alector Therapeutics and the Board of Senda Biosciences, a Flagship company. In 2021, Professor Hammond was selected to become a member of the President’s Council of Advisors on Science and Technology (PCAST).
In terms of educational background, Prof. Hammond is from Detroit, Michigan, and received her B.S. in Chemical Engineering from MIT, then worked for two years in industry, moved to Atlanta to get an M.S. in Chemical Engineering at Georgia Tech, before returning to MIT for her PhD. She held the Ford Foundation Dissertation Fellowship, and on completing her PhD, was an NSF Postdoctoral Fellow at the Harvard University Chemistry Department before returning to MIT as a faculty member.

Hsing-Wen Sung
(National Tsing Hua University, Chinese Taipei)

Hsing-Wen Sung is a Tsing Hua Distinguished Chair Professor, Department of Chemical Engineering, National Tsing Hua University. He received his PhD degree from the Department of Chemical Engineering/Biomedical Engineering Program, Georgia Institute of Technology in May 1988. His research interests are biomaterials, tissue engineering, and drug/gene delivery. Professor Sung has received numerous awards such as Fellow of American Institute for Medical and Biological Engineering, Fellow of International Union of Societies for Biomaterials Science and Engineering, Academician of Asia Pacific Academy of Materials, Ho Chin Tui Outstanding Research Award, National Science Council Outstanding Research Award, Professor Tsai-The Lai Award, Elsevier 2015 Biomaterials Best Paper Award, and 2016 TERMIS-AP Outstanding Scientist Award. He has been on the Editorial Boards of Journal of Controlled Release and Advanced Healthcare Materials; also, he has been serving as a Handling Editor for Biomaterials. Professor Sung has published 294 scientific papers and received 139 international patents. His published papers have over 31,409 citations with an H-index of approximately 97, according to Google Scholar.

Sung Yun Yang
(Chungnam National University, Korea, Republic of)

Sung Yun Yang received her B.S and M.S. from Ewha Womans University in 1991 and 1993, respectively. After serving in the Chemistry division at KRICT and KIST, in 1995 moved to USA for her doctoral degree in Polymer Chemistry and Engineering at Polytechnic University, New York University currently. In August of 2000, she moved to MIT as a postdoctoral researcher in the Department of Materials Science and Engineering. She worked in a biotech company for a year and returned to Korea in 2004 starting her professorship at Chungnam National University. Since 2004 she has been with CNU, is now a professor of Organic Materials Engineering. Along with her research and academic activity, she also served as a vice-president of the Center for Women in Science, Engineering and Technology to promote educational opportunity for woman engineers. Prof. Yang’s research interests include functional nanomaterials for energy, environmental sustainability, and biomedical application.

João F. Mano
(The University of Aveiro, Portugal)

João F. Mano is a Full Professor at the Chemistry Department of University of Aveiro, Portugal, and vice-director of the Associate Laboratory CICECO – Aveiro Instituto of Materials, where he is directing the COMPASS Research Group (http://compass.web.ua.pt/). His research interests include the use of advanced biomaterials and cells towards the progress of multidisciplinary concepts to be employed in regenerative and personalised medicine. In particular, he has been applying biomimetic and nano/micro-technology approaches to polymer-based biomaterials and cell-rich systems to develop biomedical devices with improved structural and (multi-)functional properties, or in the engineering of microenvironments to control cell behaviour and organization, to be exploited clinically in advanced therapies or in drug screening. He is the Editor-in-Chief of Materials Today Bio (Elsevier). He has been coordinating or involved in many national and European research projects, including 2 Advanced Grants and 3 Proof-of-Concept Grants from the European Research Council. João F. Mano has received different honours and awards, including two honoris causa doctorates (Univ. of Lorraine and Utrecht Univ.) and was elected fellow of the European Academy of Sciences (FEurASc), Biomaterials Science & Engineering (FBSE) and American Institute of Medical and Biological Engineering (FAIMBE).

Abhay Pandit
(University of Galway, Ireland)

Professor Abhay Pandit, spanning over 32 years, has made significant contributions to biomaterials and medical device translation. After spending seven successful years in the industry, Prof. Pandit transitioned to academia, where he has dedicated the past 25 years to his work.

A notable achievement in Prof. Pandit's career is the establishment of CÚRAM, the Science Foundation Ireland (SFI) Centre for Research in Medical Devices at the University of Galway in Ireland. Serving as a thriving hub for more than 1000 researchers, CÚRAM brings together experts from diverse disciplines including biomaterials, biomechanics, regenerative medicine, glycobiology, drug delivery, and medical implant design. Through collaborations with industry partners, the center actively fosters innovation and facilitates the translation of research into practical applications.

Prof. Pandit derives his inspiration from comprehending fundamental pathological processes influenced by glycomodulation. This understanding enables him to develop superior biomaterial substrates for materials design, with a particular focus on degenerative or chronic conditions associated with the cardiovascular, neural, and intervertebral disc domains.

Prof. Pandit has accumulated over €175 million in research contracts from industry and government funding agencies. His work has resulted in the filing of 28 patents, while 14 other patent applications are currently pending. Furthermore, Prof. Pandit has successfully licensed several technologies to medical device companies, amplifying the practical impact of his research.

Prof. Pandit's research contributions are well-documented through his publication record. He has authored more than 345 manuscripts, which have been featured in esteemed publications such as Science Advances, Nature Communication, Science Translational Medicine, PNAS, Advanced Materials, Journal of American Chemical Society, Advanced Functional Materials, Biomaterials, and Molecular Therapy. Additionally, he has presented over 715 papers at national and international conferences, further disseminating his findings and insights to the scientific community.

Prof. Pandit actively engages in editorial activities. He holds a position on the Executive Editorial Board of the Tissue Engineering journal and is the Senior Associate Editor for the Biomaterials journal. Additionally, he chairs the EU Chapter of the Tissue Engineering and Regenerative Medicine Society, showcasing his leadership and influence within the discipline.

Prof. Pandit's contributions have garnered him prestigious awards, including the George Winter Award 2022 from the European Society for Biomaterials and the Chandra P Sharma Award from the Society for Biomaterials and Artificial Organs India. Furthermore, he has been honored as a Fellow of AIMBE, TERMIS, IAE, and IUSBSE, reflecting his standing in the scientific community.

Tim Woodfield
(University of Otago, New Zealand)

Prof. Tim B. F. Woodfield, Ph.D. is Professor of Regenerative Medicine in the Department of Orthopaedic Surgery & Musculoskeletal Medicine at the University of Otago, New Zealand. He leads the Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group and is Director of the University of Otago Centre for Bioengineering & Nanomedicine. His research platform involves development of novel bioinks and bioresins, biofabrication, spheroid bioassembly and additive manufacturing of medical devices applied to regenerative medicine of cartilage and bone, advanced 3D in vitro tissue culture models, and high throughput screening.
He has published over 150 peer reviewed journal articles, book chapters and published conference proceedings and has received a number of awards and fellowships including a prestigious Rutherford Discovery Fellowship from the Royal Society of New Zealand Te Apärangi and the University of Otago Research Gold Medal. He received the 2020 Research Excellence Award from the Australasian Society for Biomaterials & Tissue Engineering (ASBTE), and was awarded Fellow, Biomaterials Science & Engineering (FBSE) in 2020 by the International Union of Societies in Biomaterials Science and Engineering (IUSBSE).
He has attracted over NZ$28 million in competitive research funding as a Principal or Associate Investigator through grants from the Ministry of Business Innovation & Employment, Royal Society of New Zealand Te Apärangi, New Zealand Health Research Council, AO Foundation, as well as the European Commission (EU-FP7).
He is the current President of the International Society for Biofabrication (ISBF) and former President of the Australasian Society for Biomaterials & Tissue Engineering (ASBTE). He sits on the Tissue Engineering and Regenerative Medicine International Society Asia Pacific (TERMIS-AP) Council and on the Executive Editorial Board for Biofabrication. He is also an Editorial Board Member for Advanced Healthcare Materials and APL Bioengineering and Associate Editor for Frontiers in Bioengineering & Biotechnology.

Ick Chan Kwon
(Korea Institute of Science and Technology, Korea, Republic of)

Dr. Ick Chan Kwon is a tenured Principal Research Scientist at the Korea Institute of Science and Technology (KIST), a Professor at Korea University (KU-KIST Graduate School), and an Affiliated Professor at the University of Washington Seattle (Department of Bioengineering). He is also a Presidential Scholar at the KIST-DFCI On-Site-Lab in the Dana Farber Cancer Institute (Department of Cancer Biology). He earned his B.S. and M.S. in Engineering from Seoul National University, as well as his Ph.D. in Pharmaceutics and Pharmaceutical Chemistry from the University of Utah. He joined KIST after completing his post-doctoral studies at the University of Utah's Center for Controlled Chemical Delivery, where he began his research on polymeric nanoparticle-based drug delivery systems for antibiotics, anticancer medicines, and gene therapy. By merging molecular imaging and drug delivery systems with smart nano-probes, he also pioneered in the field of Theragnosis research. He was the president of the Korean Society of Molecular Imaging and an editor for the Journal of Controlled Release in Asia (Elsevier). He is a senior member of Korea's National Academy of Engineering and a fellow of the Korean Academy of Science and Technology.

Ana Paula Pego
(i3S / INEB - University of Porto, Portugal)

Ana Paula Pêgo got her Ph.D. in Polymer Chemistry and Biomaterials from the University of Twente, the Netherlands, in 2002. In 2003 she moved to INEB – Instituto de Engenharia Biomédica, where she became a Principal Investigator in 2012. In 2015, INEB joined the i3S – Instituto de Investigação e Inovação em Saúde (Universidade do Porto), where Ana Paula Pêgo leads the nanoBiomaterials for Targeted Therapies (nBTT) Group.

By using nanomedicine strategies the nBTT Group, aims at providing in situ and in a targeted manner the required signals to promote nervous tissue regeneration. The research on new biomaterials for application in neurosciences includes the development of new polymers for the design of alternative vectors to viruses for efficient nucleic acid delivery, the preparation of nerve grafts for spinal cord injury treatment and the design of brain tissue engineered platforms. Societal and ethical issues that concern Regenerative Medicine and NanoMedicine are also topics in which Ana Paula Pêgo is involved.

She has been appointed the Scientific Director of the Bioimaging Centre for Biomaterials and Regenerative Therapies of INEB and she is an Invited Associate Professor at the Instituto de Ciências Biomédicas Abel Salazar (ICBAS) of the University of Porto.

Currently Ana Paula Pêgo is a member of the Board of Directors of i3S, being the Head of Strategy & Creation of Value Unit, serves as an Associate Editor of Biomaterials (Elsevier journal) and is part of the Board of Reviewing Editors of Science (AAAS).

Ana Paula Pêgo served two terms in the European Society for Biomaterials (ESB) Council, being the ESB Council Secretary from 2017-2021 and the ESB President from 2021-2023, being now the ESB past President.